Latest Press Releases
View all
TimeHeadline
YesterdayDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
YesterdayRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
YesterdayThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
YesterdayBuffalo Potash Files Annual Information Form and New Technical Report
YesterdayIonik Announces 30-Day Extension of Senior Debt Facility
Cipher Pharmaceuticals Inc. logo

Cipher Pharmaceuticals Inc.

About

16.76CAD-0.12 -0.71%
Closed • Updated at 16:32 GMT+00:00
Market Cap$307.40M
P/E Ratio10.19
Volume11.5K
Beta1.27
RSI38.63
Gross Margin67.46%
Health TechnologyPharmaceuticals: Other

Cipher Pharmaceuticals Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 7 2026
Cipher Pharmaceuticals Reports First Quarter Results
Apr 29 2026
Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call
Mar 12 2026
Cipher Pharmaceuticals Reports Fourth Quarter Results and Full Year 2025 Record Revenue and Earnings
Mar 4 2026
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call
Jan 28 2026
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)

Community Chat

Ask AI

Try asking
6ix6ixAIEvents